Skip to main content

Table 4 Association between GBS serotype and antimicrobial pattern indicating OR

From: Prevalence, antimicrobial susceptibility patterns, serotypes and risk factors for group B streptococcus rectovaginal isolates among pregnant women at Kenyatta National Hospital, Kenya; a cross-sectional study

SerotypePenicillin GAmpicillinVancomycinClindamycin
OR95% CIPOR95% CIPOR95% CIPOR95% CIP
Ia4.811.265–18.3110.0213.520.926–13.3530.0650.810.180–3.6350.7811.330.294–0.7090.71
Ib1.250.343–4.5580.7352.410.684–8.4710.1710.820.198–3.4320.791.380.312–0.6680.67
II1.080.321–3.6260.9022.730.862–8.6250.0880.540.137–2.1570.3850.330.071–0.1540.15
III1.680.490–5.7450.416.841.899–24.6720.0031.860.426–8.0870.4111.310.307–0.7140.71
IV30.717–12.5530.1325.121.372–19.0770.0151.020.254–4.1040.9770.740.158–0.7020.7
V1.170.346–3.9330.8041.330.434–4.0940.6151.50.377–5.9650.5650.760.182–0.7140.71
VI3.380.947–12.0980.0614.451.353–14.6530.0141.660.418–6.6060.471.50.351–0.5850.59
VII1.890.519–6.8680.3343.480.99–12.2420.0520.830.202–3.4350.8010.290.062–0.1240.12
VIII2.250.567–8.9270.2494.671.255–17.3580.0221.330.286–6.2140.7140.760.149–0.7460.75
IX2.250.478–10.5950.30530.676–13.3090.1480.850.141–5.0700.8550.480.087–0.3990.4
  1. GBS group b streptococcus, OR odds ratio, CI confidence interval, Number in bold are statistically significant P < 0.05